The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...

The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...

FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...

UnitedHealth Group is charging patients a markup for key life-saving drugs that could easily exceed their cost by a factor of ...

FTC’s report focused on three largest PBMs: CVS Health Corporation’s CVS Caremark, The Cigna Group’s CI Express Scripts, and UnitedHealth Group Incorporated’s UNH Optum Rx. This report ...

(Bloomberg) -- Units of CVS Health Corp., Cigna Group and UnitedHealth ... a year” and said the FTC had failed to address the underlying causes of rising drug prices. UnitedHealth’s Optum ...

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying the major industry middlemen generate billions in revenue through ...

FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging, PBMs, UnitedHealth OptumRx, CVS Caremark Rx, Express Scripts ...

But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it ...

UnitedHealth reported fourth-quarter results on Thursday that reflected persistent challenges for the health insurance sector ...